Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes
BACKGROUND:
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes
Abstract
BACKGROUND
The Falling, Wandering and Crashing Business of Cancer Treatment Side Effects
With neuropathy as a result of treatment comes a whole host of issues. The first one I can think of? Oops, there goes the wine! In more ways than one, actually, as wine is probably one of the last things you can enjoy while undergoing chemo. And not only can you not enjoy it, but when you try to lift that glass onto your kitchen counter, neuropathy will cause you to instead bash it against the edge. Hopefully this was not your special glass. If you try it again while in treatment, pick the cheap old glass you got at a yard sale. No big loss.
Woyach Highlights Progress and Next Steps in CLL Paradigm
With therapeutic additions to the treatment paradigm of chronic lymphocytic leukemia (CLL), it is now a question of which regimen to give patients in the frontline setting, explained Jennifer A. Woyach, MD.
Iron Chelation Therapy May Improve Overall Survival in Patients With Myelodysplastic Syndrome
AML Research Efforts in Full Swing After Decades of Stagnation
What's the best gift for a cancer patient or caregiver?
Finding the right gift for your friends and family can be tough. It can be even tougher if they're undergoing cancer treatment or are caring for someone who is. After all, you may be trying to make the holidays extra special for them during a difficult time.
So, we asked our some of our bloggers -- who are cancer patients, survivors and caregivers themselves -- for their holiday gift recommendations. Here's what they said.
(con't)
What Happens in a Clinical Trial? How do I know if it's the right option for me?
Why would I choose a clinical trial? What kind of additional care would I receive? How do I know if I qualify?
Christina Cline, RN, BSN, CCRC, explains both patient and nurse navigator roles in this recent recording.
Surprised by diagnosis, Mark learns to live with low-risk Myelodysplastic Syndrome
Mark had no symptoms prior to diagnosis. Even more surprising was the "watch and wait" treatment plan! Listen to this recently recorded episode where Mark describes living as an MDS survivor now.